Works matching IS 14783223 AND DT 2022 AND VI 42 AND IP 4
Results: 27
Genetics: A new clinical tool for the hepatologist.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 724, doi. 10.1111/liv.15205
- By:
- Publication type:
- Article
The NAFLD‐MAFLD debate: Is there a Consensus‐on‐Consensus methodology?
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 742, doi. 10.1111/liv.15197
- By:
- Publication type:
- Article
Atezolizumab and bevacizumab for HCC in the real world.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 727, doi. 10.1111/liv.15204
- By:
- Publication type:
- Article
Preoperative magnetic resonance imaging‐based prognostic model for mass‐forming intrahepatic cholangiocarcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 930, doi. 10.1111/liv.15196
- By:
- Publication type:
- Article
Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 820, doi. 10.1111/liv.15195
- By:
- Publication type:
- Article
Vaccination against COVID‐19 decreases hospitalizations in patients with cirrhosis: Results from a nationwide analysis.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 942, doi. 10.1111/liv.15193
- By:
- Publication type:
- Article
Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three‐arm study.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 775, doi. 10.1111/liv.15191
- By:
- Publication type:
- Article
Stenting of ductus venosus as a palliation for portal hypertension because of neonatal cirrhosis.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 879, doi. 10.1111/liv.15190
- By:
- Publication type:
- Article
Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 864, doi. 10.1111/liv.15185
- By:
- Publication type:
- Article
Risk factors for bleeding hepatocellular adenoma.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 947, doi. 10.1111/liv.15184
- By:
- Publication type:
- Article
Anti‐CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non‐alcoholic steatohepatitis models.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 829, doi. 10.1111/liv.15182
- By:
- Publication type:
- Article
Hepatocellular carcinoma and HBsAg loss after cessation of antiviral therapy.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 945, doi. 10.1111/liv.15179
- By:
- Publication type:
- Article
Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 871, doi. 10.1111/liv.15177
- By:
- Publication type:
- Article
Patient‐specific genetic factors predict treatment failure in sofosbuvir‐treated patients with chronic hepatitis C.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 796, doi. 10.1111/liv.15175
- By:
- Publication type:
- Article
Alcohol‐related hepatitis admissions increased 50% in the first months of the COVID‐19 pandemic in the USA.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 762, doi. 10.1111/liv.15172
- By:
- Publication type:
- Article
Efficacy and safety of percutaneous cryoablation for elderly patients with small hepatocellular carcinoma: A prospective multicenter study.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 918, doi. 10.1111/liv.15169
- By:
- Publication type:
- Article
Non‐selective beta‐blockers in patients with ascites: The complex interplay among the liver, kidney and heart.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 749, doi. 10.1111/liv.15166
- By:
- Publication type:
- Article
Roles for the mycobiome in liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 729, doi. 10.1111/liv.15160
- By:
- Publication type:
- Article
Adherence to the dietary approaches to stop hypertension diet and non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 809, doi. 10.1111/liv.15156
- By:
- Publication type:
- Article
Prognosis of hospitalized patients with cirrhosis and acute kidney disease.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 896, doi. 10.1111/liv.15154
- By:
- Publication type:
- Article
Can alcohol control policies reduce cirrhosis mortality? An interrupted time‐series analysis in Lithuania.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 765, doi. 10.1111/liv.15151
- By:
- Publication type:
- Article
Presence of multilobular necrosis on liver biopsy identifies corticosteroid responsiveness in acute indeterminate hepatitis.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 853, doi. 10.1111/liv.15144
- By:
- Publication type:
- Article
Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 905, doi. 10.1111/liv.15129
- By:
- Publication type:
- Article
Estimated glomerular filtration rate by formulas in patients with cirrhosis: An unreliable procedure.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 884, doi. 10.1111/liv.15134
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of hepatitis C virus (HCV) point‐of‐care assay for HCV screening.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 787, doi. 10.1111/liv.15123
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 719, doi. 10.1111/liv.14954
- Publication type:
- Article
Brain metabolic and microstructural alterations associated with hepatitis C virus infection, autoimmune hepatitis and primary biliary cholangitis.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 842, doi. 10.1111/liv.15093
- By:
- Publication type:
- Article